METSY Consortium to Develop Neuroimaging, Bioinformatics Tools for Psychosis Biomarker Studies | GenomeWeb

This article has been updated to include comments from Biomax Informatics about its participation in the consortium.

A newly launched European consortium studying links between lipid metabolism, psychotic disorders, and metabolic co-morbidities such as metabolic syndrome and diabetes will also develop neuroimaging and bioinformatics tools to locate possible diagnostic biomarkers of psychosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.